Invesco Ltd. Precigen, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Precigen, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 41,267 shares of PGEN stock, worth $29,299. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,267

Previous 41,535 0.65%

Holding current value

$29,299

Previous $65,000 40.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$0.91 - $1.88 $243 - $503	-268 Reduced 0.65%	41,267 $39,000
Q2 2024 Aug 13, 2024	SELL	$1.27 - $1.75 $3,907 - $5,384	-3,077 Reduced 6.9%	41,535 $65,000
Q1 2024 May 14, 2024	BUY	$1.21 - $1.75 $156 - $225	129 Added 0.29%	44,612 $64,000
Q4 2023 Feb 12, 2024	BUY	$0.89 - $1.41 $11,533 - $18,272	12,959 Added 41.11%	44,483 $59,000
Q3 2023 Nov 13, 2023	BUY	$1.08 - $1.85 $227 - $390	211 Added 0.67%	31,524 $44,000
Q2 2023 Aug 11, 2023	SELL	$0.96 - $1.4 $95,768 - $139,662	-99,759 Reduced 76.11%	31,313 $36,000
Q1 2023 May 12, 2023	BUY	$0.88 - $2.19 $77,928 - $193,935	88,555 Added 208.28%	131,072 $138,000
Q4 2022 Feb 13, 2023	SELL	$1.27 - $2.26 $4,845 - $8,621	-3,815 Reduced 8.23%	42,517 $64,000
Q3 2022 Nov 14, 2022	BUY	$1.41 - $2.79 $5,556 - $10,995	3,941 Added 9.3%	46,332 $98,000
Q2 2022 Aug 15, 2022	SELL	$1.15 - $2.53 $2,509 - $5,520	-2,182 Reduced 4.9%	42,391 $57,000
Q1 2022 May 16, 2022	BUY	$1.91 - $3.98 $1,759 - $3,665	921 Added 2.11%	44,573 $93,000
Q4 2021 Feb 14, 2022	SELL	$3.53 - $5.5 $22,754 - $35,453	-6,446 Reduced 12.87%	43,652 $162,000
Q3 2021 Nov 15, 2021	SELL	$4.99 - $6.55 $5.78 Million - $7.59 Million	-1,158,616 Reduced 95.86%	50,098 $251,000
Q2 2021 Aug 17, 2021	BUY	$6.24 - $8.22 $1.61 Million - $2.12 Million	258,280 Added 27.17%	1,208,714 $7.88 Million
Q1 2021 May 17, 2021	SELL	$6.74 - $10.95 $1.93 Million - $3.14 Million	-286,354 Reduced 23.15%	950,434 $6.55 Million
Q4 2020 Feb 16, 2021	BUY	$3.75 - $10.56 $4.45 Million - $12.5 Million	1,187,104 Added 2389.31%	1,236,788 $12.6 Million
Q3 2020 Nov 16, 2020	SELL	$3.5 - $6.2 $2.78 Million - $4.92 Million	-793,769 Reduced 94.11%	49,684 $174,000
Q2 2020 Aug 14, 2020	BUY	$2.16 - $5.46 $1.72 Million - $4.34 Million	795,332 Added 1652.78%	843,453 $4.21 Million
Q1 2020 May 15, 2020	BUY	$1.46 - $7.19 $70,256 - $345,989	48,121 New	48,121 $163,000

Others Institutions Holding PGEN

# of Institutions

143

Shares Held

159M

Call Options Held

232K

Put Options Held

69K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $148M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account